PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 1 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,815 | +15.0% | 3,500 | +67.5% | 0.00% | – |
| Q2 2023 | $9,405 | +12275.0% | 2,090 | -84.3% | 0.00% | -100.0% |
| Q1 2023 | $76 | +261.9% | 13,352 | +278.0% | 0.00% | +100.0% |
| Q4 2022 | $21 | -99.8% | 3,532 | +181.7% | 0.00% | – |
| Q3 2022 | $9,000 | -57.1% | 1,254 | -68.8% | 0.00% | – |
| Q2 2022 | $21,000 | +31.2% | 4,024 | +72.3% | 0.00% | – |
| Q1 2022 | $16,000 | -75.8% | 2,335 | -56.1% | 0.00% | -100.0% |
| Q4 2021 | $66,000 | -39.4% | 5,320 | +52.0% | 0.00% | -66.7% |
| Q3 2021 | $109,000 | +251.6% | 3,499 | +228.5% | 0.00% | +200.0% |
| Q2 2021 | $31,000 | -74.6% | 1,065 | -62.0% | 0.00% | -50.0% |
| Q1 2021 | $122,000 | +713.3% | 2,805 | +1268.3% | 0.00% | – |
| Q4 2020 | $15,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,909,256 | $33,709,601 | 0.72% |
| Boxer Capital, LLC | 2,495,018 | $7,709,606 | 0.41% |
| Sio Capital Management, LLC | 350,000 | $1,081,500 | 0.34% |
| Baker Brothers Advisors | 10,123,824 | $31,282,616 | 0.18% |
| EcoR1 Capital, LLC | 1,157,452 | $3,576,527 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 70,583 | $218 | 0.02% |
| Pale Fire Capital SE | 30,781 | $95,113 | 0.01% |
| Woodline Partners LP | 200,000 | $618,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 143,957 | $444,827 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 32,907 | $101,683 | 0.00% |